Aktiesnakken — November 2010
-
deres forskningsudgifter for kvartalet må være ekstraordinære lave...
-
for de brugte kun 20 mill...så jeg tror ikke vi kan fremføre det tal i vores regneark
-
det kan vi derimod på administrationen der gik fra 40 mill til 26 mill....
-
ja Hrmunk...sådan ser jeg det også....
-
jeg er faneme slidt her til aften kan slet ikke se ud af øjnene. Udover børsen har nogen så skrevet noget om Genmab?
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind